ITGR•October 29, 2026 at 12:00 PM UTCHealth Care Equipment & Services

Integer Holdings Q3 2026 Sales Decline 3.9% to $450M, Confirming Expected Headwinds

Read source article

What happened

Integer Holdings reported third quarter 2026 sales of $450 million, a 3.9% decrease compared to the same period in 2025. This marks a sharp reversal from the 11.4% year-over-year growth seen in Q2 2025. The decline aligns with management's prior warning of 2026 headwinds and their plan to return to above-market organic growth only in 2027. While the decrease was anticipated, the magnitude and breadth across product lines will be critical to assess. Further details on profitability and updated guidance are needed to fully evaluate the impact on the company's valuation.

Implication

The decline is consistent with the company's warning of 2026 headwinds, so it is unlikely to shock the market significantly. However, investors should assess whether the decline is concentrated in specific product lines or broad-based. If margins also compress, the high valuation (P/E ~30, EV/EBITDA ~58) may become harder to justify. The key watch item remains the company's ability to return to above-market growth in 2027, as management has guided. Until there is clarity on the trajectory, maintaining a HOLD and waiting for a better entry point seems prudent.

Thesis delta

The thesis remains a HOLD. The Q3 2026 sales decline aligns with management's prior warning of 2026 headwinds, and thus does not represent a major surprise. However, if the decline is broader or deeper than expected, it could trigger a downgrade to SELL.

Confidence

Medium